Toxic epidermal necrolysis (TEN) is a type of drug eruption in dermatology emergencies that is rare in clinical practice but has a high mortality rate. The main causes are drug and viral infections. Unfortunately, no expert consensus on treating this disease exists, and a standard therapy is absent. Up to now, glucocorticoids combined with gamma globulin are commonly used in clinical practice, but their efficacy is highly controversial. This study reports on a 7-year-old girl with TEN who did not respond to traditional therapy, such as methylprednisolone combined with gamma globulin, but was finally cured with an additional low-dose etanercept. The results showed that etanercept therapy in paediatric TEN is safe, reliable and worth recommending.
Keyphrases
- clinical practice
- rheumatoid arthritis
- low dose
- ankylosing spondylitis
- rheumatoid arthritis patients
- juvenile idiopathic arthritis
- emergency department
- intensive care unit
- young adults
- sars cov
- adverse drug
- stem cells
- risk factors
- cardiovascular disease
- type diabetes
- cardiovascular events
- wound healing
- disease activity
- cell therapy